Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.
about
Scavenger receptor SR-BI in macrophage lipid metabolismIdentification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levelsExpression of scavenger receptor class B type I in gallbladder columnar epitheliumScavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systemsHepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in micePanax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory actionRare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseaseAssociation of the Lipoprotein Receptor SCARB1 Common Missense Variant rs4238001 with Incident Coronary Heart DiseaseLoss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection.Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsisScavenger receptor BI facilitates hepatic very low density lipoprotein production in mice.Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese miceRole of the adaptor protein PDZK1 in controlling the HDL receptor SR-BIGenomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12.Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?ATP Synthase β-Chain Overexpression in SR-BI Knockout Mice Increases HDL Uptake and Reduces Plasma HDL LevelHepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.Novel lipid-regulating drugs.Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice.High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.High-density lipoprotein: gene-based approaches to the prevention of atherosclerosis.Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseSR-BI/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport.Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterolDiscovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.Association between paraoxonase gene and stroke in the Han Chinese population.Recent advances in liver-directed gene therapy for dyslipidemia.Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BIExpression, purification and reconstitution of the C-terminal transmembrane domain of scavenger receptor BI into detergent micelles for NMR analysis.Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein.SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction.Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport.Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissuesRosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
P2860
Q24299462-D4677E04-87AC-409F-B26E-71D16289CCBCQ28204853-99112187-46C8-4A63-965C-FA8FB24A38A5Q28213114-569EDA8C-86DF-40CC-9578-901E01576455Q28354246-EB54BA5A-218E-4968-9DA3-40780B51DA0DQ28513943-08F6FACA-DC7F-4869-9F36-35A086EB03AEQ28569709-AE8BB46F-7A0E-4741-B242-F4E81B44A954Q29147547-8EEA280D-1D83-47D5-8655-E4859FAA1AC0Q30299909-97D961DA-7144-41C6-A9C4-179CAE018E0EQ30942732-FFD58E7A-759B-4B50-A63D-08E47C82CF09Q33180043-4FB2A9AB-CA8A-4FB8-83FF-3DBF5E605C3EQ33567588-573E4E7B-98C2-4C49-B748-BEAAED917180Q33634141-96CF4DAD-9B9B-48E0-90BF-0CE9E5BD0168Q33661459-E7F5F3C2-3F7D-4970-ABEF-69B8DB08DBCBQ33750744-D98D058C-DAD5-48C0-9A9F-7FCBA73B29C4Q33767978-8CA07E16-B0AC-4428-A7EA-5785A75B4EC4Q33909610-BDAC31C0-BC9D-42C2-BC65-02D6AB00E34DQ33937822-98DBEA7D-CCF7-4F3D-BD76-68417DEF94DDQ33993233-9A04E2C5-02DD-4776-871F-4706D2D4F303Q33997963-3A610160-66DA-4F3E-9DBA-F1C75A1A5C03Q34048490-52D306C4-39A9-481F-92B7-4EEA04D8A5CCQ34075175-2153FC56-726F-4952-AD17-75B79CA491D7Q34088392-87FBFECB-9EC6-4BF7-AABE-14040B32FD9EQ34107511-3033BF48-DD9B-493B-97A3-87281370B9ABQ34157567-82C1EF5E-D7FC-45FF-A96D-15C7C311FEBFQ34198844-F90300ED-883E-4753-957A-E58B98A79625Q34218552-235E2A87-BE8B-4A31-BFA5-24EE04221D89Q34300349-718B1A9B-9539-430E-83DF-F1C861FB4915Q34315738-55DFEA1F-CFAF-4447-907B-64F13ADDFFFEQ34386663-90492381-5AFF-4585-8001-806F6E9AA3A6Q34479025-46AC3BF8-F6F9-4790-BAF2-B1EB21488477Q34565333-B59DB9DA-DE6D-4DBB-BF3D-BA9D77FB5FCFQ34586826-F8C9D7F4-DBDE-4870-86BF-075DAC7E8898Q34726050-EEF14550-6646-4C54-9E90-317F88B47664Q34734451-62B064BA-E653-41E9-AD7A-5365EEA9547FQ34786703-68E1617F-3C1E-440C-8391-99FD8C9048B1Q34965254-5CDF303A-3E66-4763-B120-385CD522CCBDQ34998020-56F3ADD8-21CD-4AB6-AB60-F9822784D91AQ35017869-F4B29D4F-CFCB-4980-9A61-4F88F6AA79A6Q35040072-1712D932-163D-4646-A1E1-49A4D7A9DEC3Q35103176-57371ABD-D800-451E-A34E-5579313DC4BA
P2860
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@en
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@nl
type
label
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@en
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@nl
prefLabel
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@en
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@nl
P2093
P356
P1476
Gene transfer and hepatic over ...... LDL receptor-deficient mouse.
@en
P2093
P304
P356
10.1161/01.ATV.20.3.721
P407
P577
2000-03-01T00:00:00Z